These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 23513230

  • 1. Diagnostic and prognostic value of immunocytochemistry and BRAF mutation analysis on liquid-based biopsies of thyroid neoplasms suspicious for carcinoma.
    Rossi ED, Martini M, Capodimonti S, Straccia P, Cenci T, Lombardi CP, Pontecorvi A, Larocca LM, Fadda G.
    Eur J Endocrinol; 2013 Jun; 168(6):853-9. PubMed ID: 23513230
    [Abstract] [Full Text] [Related]

  • 2. Detection of BRAF c.1799T > A (p.V600E) mutation using residual routine fine-needle aspiration specimens of papillary thyroid carcinoma.
    Zhao H, Zhang ZH, Zhou B, Xiao T, Pan QJ, Guo HQ.
    Diagn Cytopathol; 2015 Oct; 43(10):786-90. PubMed ID: 26152656
    [Abstract] [Full Text] [Related]

  • 3. Mutant-specific BRAF and CD117 immunocytochemistry potentially facilitate risk stratification for papillary thyroid carcinoma in fine-needle aspiration biopsy specimens.
    Meng Z, Lu J, Wu H, Zhao Y, Luo Y, Gao J, Zhu Q, Jiang Y, Li W, Liang Z.
    Tumour Biol; 2016 Jan; 37(1):611-8. PubMed ID: 26240026
    [Abstract] [Full Text] [Related]

  • 4. BRAF (V600E) mutation analysis on liquid-based cytology-processed aspiration biopsies predicts bilaterality and lymph node involvement in papillary thyroid microcarcinoma.
    Rossi ED, Martini M, Capodimonti S, Lombardi CP, Pontecorvi A, Vellone VG, Zannoni GF, Larocca LM, Fadda G.
    Cancer Cytopathol; 2013 Jun; 121(6):291-7. PubMed ID: 23192956
    [Abstract] [Full Text] [Related]

  • 5. Pilot of BRAF mutation analysis in indeterminate, suspicious and malignant thyroid FNA cytology.
    Johnson SJ, Hardy SA, Roberts C, Bourn D, Mallick U, Perros P.
    Cytopathology; 2014 Jun; 25(3):146-54. PubMed ID: 24417615
    [Abstract] [Full Text] [Related]

  • 6. Morphological features that can predict BRAFV600E -mutated carcinoma in paediatric thyroid cytology.
    Rossi ED, Bizzarro T, Martini M, Capodimonti S, Cenci T, Fadda G, Schmitt F, Larocca LM.
    Cytopathology; 2017 Feb; 28(1):55-64. PubMed ID: 27256275
    [Abstract] [Full Text] [Related]

  • 7. BRAF mutation testing of thyroid fine-needle aspiration specimens enhances the predictability of malignancy in thyroid follicular lesions of undetermined significance.
    Adeniran AJ, Hui P, Chhieng DC, Prasad ML, Schofield K, Theoharis C.
    Acta Cytol; 2011 Feb; 55(6):570-5. PubMed ID: 22156468
    [Abstract] [Full Text] [Related]

  • 8. Detection of the BRAF(V600E) mutation in fine needle aspiration cytology of thyroid papillary microcarcinoma cells selected by manual macrodissection: an easy tool to improve the preoperative diagnosis.
    Marchetti I, Iervasi G, Mazzanti CM, Lessi F, Tomei S, Naccarato AG, Aretini P, Alberti B, Di Coscio G, Bevilacqua G.
    Thyroid; 2012 Mar; 22(3):292-8. PubMed ID: 22181337
    [Abstract] [Full Text] [Related]

  • 9. BRAF V600E mutation analysis increases diagnostic accuracy for papillary thyroid carcinoma in fine-needle aspiration biopsies.
    Zatelli MC, Trasforini G, Leoni S, Frigato G, Buratto M, Tagliati F, Rossi R, Cavazzini L, Roti E, degli Uberti EC.
    Eur J Endocrinol; 2009 Sep; 161(3):467-73. PubMed ID: 19574281
    [Abstract] [Full Text] [Related]

  • 10. Uncommon BRAF mutations in the follicular variant of thyroid papillary carcinoma: New insights.
    Rossi ED, Martini M, Bizzarro T, Capodimonti S, Cenci T, Lombardi CP, Pontecorvi A, Fadda G, Larocca LM.
    Cancer Cytopathol; 2015 Oct; 123(10):593-602. PubMed ID: 26230187
    [Abstract] [Full Text] [Related]

  • 11. BRAF p.Val600Glu (V600E) mutation detection in thyroid fine needle aspiration cell block samples: a feasibility study.
    Leslie C, Grieu-Iacopetta F, Richter A, Platten M, Murray J, Frost FA, Amanuel B, Kumarasinghe MP.
    Pathology; 2015 Aug; 47(5):432-8. PubMed ID: 26154146
    [Abstract] [Full Text] [Related]

  • 12. BRAF mutation analysis of fine-needle aspiration biopsies of papillary thyroid carcinoma: impact on diagnosis and prognosis.
    Colanta A, Lin O, Tafe L, Ghossein R, Nafa K, Mitchell T, Ladanyi M, Arcila M.
    Acta Cytol; 2011 Aug; 55(6):563-9. PubMed ID: 22156467
    [Abstract] [Full Text] [Related]

  • 13. Clinical implication of highly sensitive detection of the BRAF V600E mutation in fine-needle aspirations of thyroid nodules: a comparative analysis of three molecular assays in 4585 consecutive cases in a BRAF V600E mutation-prevalent area.
    Lee ST, Kim SW, Ki CS, Jang JH, Shin JH, Oh YL, Kim JW, Chung JH.
    J Clin Endocrinol Metab; 2012 Jul; 97(7):2299-306. PubMed ID: 22500044
    [Abstract] [Full Text] [Related]

  • 14. Use of BRAF v600e immunocytochemistry on FNA direct smears of papillary thyroid carcinoma.
    Wobker SE, Kim LT, Hackman TG, Dodd LG.
    Cancer Cytopathol; 2015 Sep; 123(9):531-9. PubMed ID: 26080065
    [Abstract] [Full Text] [Related]

  • 15. Role of ultrasonographic/clinical profile, cytology, and BRAF V600E mutation evaluation in thyroid nodule screening for malignancy: a prospective study.
    Rossi M, Buratto M, Bruni S, Filieri C, Tagliati F, Trasforini G, Rossi R, Beccati MD, Degli Uberti EC, Zatelli MC.
    J Clin Endocrinol Metab; 2012 Jul; 97(7):2354-61. PubMed ID: 22535974
    [Abstract] [Full Text] [Related]

  • 16. How limited molecular testing can also offer diagnostic and prognostic evaluation of thyroid nodules processed with liquid-based cytology: Role of TERT promoter and BRAF V600E mutation analysis.
    Dell'Aquila M, Fiorentino V, Martini M, Capodimonti S, Cenci T, Lombardi CP, Raffaelli M, Pontecorvi A, Fadda G, Pantanowitz L, Larocca LM, Rossi ED.
    Cancer Cytopathol; 2021 Oct; 129(10):819-829. PubMed ID: 34076961
    [Abstract] [Full Text] [Related]

  • 17. A morpho-molecular diagnosis of papillary thyroid carcinoma: BRAF V600E detection as an important tool in preoperative evaluation of fine-needle aspirates.
    Marchetti I, Lessi F, Mazzanti CM, Bertacca G, Elisei R, Coscio GD, Pinchera A, Bevilacqua G.
    Thyroid; 2009 Aug; 19(8):837-42. PubMed ID: 19534623
    [Abstract] [Full Text] [Related]

  • 18. The value of the repeated examination of BRAF V600E mutation status in diagnostics of papillary thyroid cancer.
    Beiša A, Beiša V, Stoškus M, Ostanevičiūtė E, Griškevičius L, Strupas K.
    Endokrynol Pol; 2016 Aug; 67(1):35-40. PubMed ID: 26884113
    [Abstract] [Full Text] [Related]

  • 19. Utility of BRAF mutation detection in fine-needle aspiration biopsy samples read as "suspicious for papillary thyroid carcinoma".
    Jara SM, Bhatnagar R, Guan H, Gocke CD, Ali SZ, Tufano RP.
    Head Neck; 2015 Dec; 37(12):1788-93. PubMed ID: 24989827
    [Abstract] [Full Text] [Related]

  • 20. BRAF analysis by fine needle aspiration biopsy of thyroid nodules improves preoperative identification of papillary thyroid carcinoma and represents a prognostic factor. A mono-institutional experience.
    Pelizzo MR, Boschin IM, Barollo S, Pennelli G, Toniato A, Zambonin L, Vianello F, Piotto A, Ide EC, Pagetta C, Sorgato N, Torresan F, Girelli ME, Nacamulli D, Mantero F, Mian C.
    Clin Chem Lab Med; 2011 Feb; 49(2):325-9. PubMed ID: 21175381
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.